Alexandra G. Cornell

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 295 citations

Medicine, Pediatrics, Pharmacotherapy +12

Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death

Marc Humbert, Vallerie V. McLaughlin, David B. Badesch et al. · New England Journal of Medicine · 2025 · 117 citations

Medicine, Pharmacology, Pharmacotherapy +10

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial

Félix Ratjen, Stephanie D. Davis, Sanja Stanojevic et al. · The Lancet Respiratory Medicine · 2019 · 115 citations

Pharmacy, Child Health, Pediatrics +11

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Domestic airborne black carbon and exhaled nitric oxide in children in NYC

Alexandra G. Cornell, Steven N. Chillrud, Robert B. Mellins et al. · Journal of Exposure Science & Environmental Epidemiology · 2012 · 60 citations

Public Health, Child Health, Air Pollution +12